Lobbying client

EQUIMED CORP

Provider of remote monitoring for implantable cardiac monitoring devices.

Filings
16
Filed by
1
Reported in-house
—
Reported by firms
$130,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2023 to 2026

Filings

16 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination (No Activity)
3rd Quarter 2026
FOLEY & LARDNER LLP — reported
2nd Quarter - Report
2nd Quarter 2026
FOLEY & LARDNER LLP $10,000 reported
1st Quarter - Report
1st Quarter 2026
FOLEY & LARDNER LLP $10,000 reported
4th Quarter - Report
4th Quarter 2025
FOLEY & LARDNER LLP $10,000 reported
3rd Quarter - Report
3rd Quarter 2025
FOLEY & LARDNER LLP $10,000 reported
2nd Quarter - Report
2nd Quarter 2025
FOLEY & LARDNER LLP $10,000 reported
1st Quarter - Report
1st Quarter 2025
FOLEY & LARDNER LLP $10,000 reported
4th Quarter - Report
4th Quarter 2024
FOLEY & LARDNER LLP $10,000 reported
3rd Quarter - Report
3rd Quarter 2024
FOLEY & LARDNER LLP $10,000 reported
2nd Quarter - Report
2nd Quarter 2024
FOLEY & LARDNER LLP $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FOLEY & LARDNER LLP 14 $130,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 14

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.